These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1779394)

  • 1. Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome.
    Tubman TR; Halliday HL; Normand C
    J Perinat Med; 1991; 19 Suppl 1():403-7. PubMed ID: 1779394
    [No Abstract]   [Full Text] [Related]  

  • 2. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis.
    Merritt TA; Hallman M; Vaucher Y; McFeeley E; Tubman TR
    J Perinatol; 1990 Dec; 10(4):416-9. PubMed ID: 2126034
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study.
    Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E
    Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic consequences of surfactant therapy.
    Eidelman AI
    J Perinatol; 1993; 13(2):137-9. PubMed ID: 8515307
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of severe respiratory distress syndrome treated with a surfactant of porcine origin (curosurf)].
    Valls i Soler A; Román Echevarría L; Setién Aqueche G; López Heredia de Goya J
    An Esp Pediatr; 1990 Aug; 33(2):160-2. PubMed ID: 2275499
    [No Abstract]   [Full Text] [Related]  

  • 8. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G
    Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant: replacement, and more.
    Costarino AT; Godinez RI
    Crit Care Med; 2000 Oct; 28(10):3563. PubMed ID: 11057819
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation.
    Marraro G; Foresti B; Casiraghi G; Monici Preti P
    Drugs Exp Clin Res; 1991; 17(10-11):511-5. PubMed ID: 1841041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.
    Tubman TR; Halliday HL; Normand C
    BMJ; 1990 Oct; 301(6756):842-5. PubMed ID: 2126475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10 Years of research on porcine derived lung surfactant. Proceedings and abstracts of the 10th International Workshop on Surfactant Replacement. Versailles, France, May 14-16, 1995.
    Biol Neonate; 1995; 67 Suppl 1():1-92. PubMed ID: 7647154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
    Bevilacqua G; Halliday H; Parmigiani S; Robertson B
    J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of surfactant administration in neonates with respiratory distress syndrome. III. The role of intra-uterine stimulation on lung maturity].
    Gadzinowski J; Halliday H; Szymankiewicz M; Breborowicz G; Sackey S; Sobczak E
    Ginekol Pol; 1993 Feb; 64(2):74-7. PubMed ID: 8359730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On exogenous surfactant therapy.
    Merritt TA; Halliday HL
    Pediatr Pulmonol; 1992 Sep; 14(1):1-3. PubMed ID: 1437336
    [No Abstract]   [Full Text] [Related]  

  • 20. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.